帕金森病移植细胞分布增强的经轴位壳核内轨迹的临床前评估
研究在9只免疫抑制、未损毁的食蟹猴中,经实时术中MRI引导,采用经轴位入路向壳核注射载体或人诱导多能干细胞来源的多巴胺能神经祖细胞(DANPCs,0.9×10^5至1.1×10^5个细胞/µL),评估该新型手术入路的可行性与安全性。术中MRI确认所有动物注射均靶向壳核内,全部动物存活至计划终止且无神经功能缺损的临床证据。作者结论认为该递送系统、注射程序和DANPCs在所有动物中耐受良好,支持临床研究。
要点
- 经轴位入路经术中MRI证实可在全部动物中成功靶向壳核内注射。
- 全部动物存活至计划终止,无神经功能缺损的临床证据。
- 早期4只动物出现轻度脑肿胀,其中3只有一过性视力下降,经甘露醇和减少术中静脉输液处理。
核心结论
- 该递送系统、注射程序和DANPCs在所有动物中耐受良好。
- 术中给予甘露醇并减少静脉输液可预防轻度脑肿胀,从而避免视觉影响。
- 该新型经轴位入路可正确且安全地将细胞注射靶向至后连合壳核,支持临床研究。
研究设计与样本
- 研究使用9只免疫抑制、未损毁的成年食蟹猴(4只雌性、5只雄性),接受壳核内注射载体或DANPCs(0.9×10^5至1.1×10^5个细胞/µL)。
- 注射在实时术中MRI引导下进行,输注液加入1 mM钆特醇以便术中MRI显像,每侧半球经腹侧和背侧两条轨迹以经轴位入路递送。
- 右侧和左侧壳核的总输注体积分别为25 µL和50 µL,输注速率为2.5 µL/min。
- 动物接受一组临床和行为结局指标评估,并于术后7天或30天安乐死,由委员会认证的兽医病理学家进行完整尸检。
- 脑组织 collected 并处理用于免疫组化,包括针对人特异性标志物STEM121的染色。
主要发现
- 优化的手术技术和工具通过经轴位入路成功靶向壳核。
- 术中MR图像确认所有动物的壳核内注射均在靶点上。
- 全部动物存活至计划终止,无神经功能缺损的临床证据。
- 最早接受手术的4只动物在手术结束时出现轻度脑肿胀,其中3只出现一过性视力下降;给予甘露醇治疗并减少术中静脉输液后这些并发症得到解决。
- 针对STEM121的免疫染色证实,在DANPC治疗动物的靶向壳核区域内,注射轨迹沿线存在移植细胞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to develop and evaluate the feasibility and safety of a novel transaxial surgical approach for the delivery of human induced pluripotent stem cell-derived dopaminergic neuroprogenitor cells (DANPCs) into the putamen nucleus using nonhuman primates and surgical techniques and tools relevant to human clinical translation. METHODS: Nine immunosuppressed, unlesioned adult cynomolgus macaques (4 females, 5 males) received intraputaminal injections of vehicle or DANPCs (0.9 × 105 to 1.1 × 105 cells/µL) under real-time intraoperative MRI guidance. The infusates were combined with 1-mM gadoteridol (for intraoperative MRI visualization) and delivered via two tracks per hemisphere (ventral and dorsal) using a transaxial approach. The total volumes of infusion were 25 µL and 50 µL for the right and left putamen, respectively (infusion rate 2.5 µL/min). Animals were evaluated with a battery of clinical and behavioral outcome measures and euthanized 7 or 30 days postsurgery; full necropsies were performed by a board-certified veterinary pathologist. Brain tissues were collected and processed for immunohistochemistry, including against the human-specific marker STEM121. RESULTS: The optimized surgical technique and tools produced successful targeting of the putamen via the transaxial approach. Intraoperative MR images confirmed on-target intraputaminal injections in all animals. All animals survived to scheduled termination without clinical evidence of neurological deficits. The first 4 animals to undergo surgery had mild brain swelling noted at the end of surgery, of which 3 had transient reduced vision; administration of mannitol therapy and reduced intravenous fluid during the surgical procedure addressed these complications. Immunostaining against STEM121 confirmed the presence of grafted cells along the injection track within the targeted putamen area of DANPC-treated animals. All adverse histological findings were limited in scope and consistent with surgical manipulation, injection procedure, and postsurgical inflammatory response to the mechanical disruption caused by the cannula insertion. CONCLUSIONS: The delivery system, injection procedure, and DANPCs were well tolerated in all animals. Prevention of mild brain swelling by mannitol dosing and reduction of intravenous fluids during surgery allowed visual effects to be avoided. The results of the study established that this novel transaxial approach can be used to correctly and safely target cell injections to the postcommissural putamen and support clinical investigation.
引用
- Emborg ME, Mancinelli A, Colwell JC, et al. Preclinical evaluation of transaxial intraputaminal trajectory for enhanced distribution of grafted cells in Parkinson's disease. J Neurosurg. 2024. PMID: 39059426. doi:10.3171/2024.4.JNS24367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。